Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Psoriasis
100%
Atopic Dermatitis
75%
Diseases
73%
Epidermolysis Bullosa Dystrophica
39%
Epidermolysis bullosa
37%
Neoplasm
27%
Systemic Therapy
27%
Dermatosis
24%
Melanoma
22%
Systematic Review
22%
Ultraviolet Radiation
21%
Biological Product
20%
Keratinocyte
20%
Eczema
20%
Dermatology
20%
Cohort Analysis
17%
Erythema
16%
COVID-19
16%
Methotrexate
15%
Malignant Neoplasm
15%
Skin Fragility
15%
Skin Disease
15%
Sunscreen
14%
Biological Therapy
14%
Psoriasis Vulgaris
14%
Fibroblast
14%
Disease
13%
Genodermatosis
13%
Ectodermal Dysplasia
13%
Dermatitis
13%
Clinical Trial
12%
Autosomal Recessive Inheritance
12%
Skin Cancer
12%
Odds Ratio
11%
Prevalence
11%
Clinician
11%
Biological Marker
11%
Collagen Type 7
11%
In Vitro
11%
Cohort Effect
11%
Meta-Analysis
10%
Infection
10%
Randomized Controlled Trial
10%
Quality of Life
10%
Vitamin D
9%
Clinical Feature
9%
Poikiloderma
9%
Skin Carcinoma
9%
Skin Type
9%
Psoriasis Area and Severity Index
9%
Immunotherapy
8%
Palmoplantar Keratoderma
8%
Adverse Event
8%
Pruritus
8%
Comorbidity
8%
Inflammatory Disorder
8%
Adalimumab
8%
Immunoglobulin E
8%
Autosomal Dominant Inheritance
8%
Desmosome
8%
Immunosuppressive Treatment
8%
Immune Response
8%
Desmoplakin
8%
Psoriatic Arthritis
8%
Placebo
8%
Sunburn
8%
Exon
7%
Health Care Cost
7%
Cancer
7%
T Cell
7%
Generalized Pustular Psoriasis
7%
Missense Mutation
7%
Pustular Psoriasis
7%
Cyclosporine
7%
Keratin
7%
Cell Therapy
6%
Lipoid Proteinosis
6%
Ustekinumab
6%
Induced Pluripotent Stem Cell
6%
Nail
6%
Macrophage
6%
Immunomodulating Agent
6%
Primary Health Care
6%
B Cell
6%
Pathophysiology
6%
Hair Follicle
6%
Nonsense Mutation
6%
Squamous Cell Carcinoma
6%
Volunteer
6%
Cancer Therapy
6%
Cross Sectional Study
5%
Synapsin I
5%
Observational Study
5%
Antibody-Drug Conjugate
5%
Autoimmunity
5%
Phototherapy
5%
Extracellular Matrix Protein
5%
Loss of Function Mutation
5%
Patient Referral
5%
Pediatrics
5%
Immunology and Microbiology
Atopic Dermatitis
56%
Immunoglobulin E
41%
Eczema
34%
Keratinocyte
25%
Dermatitis
23%
Immune Response
20%
T Cell
19%
Immunotherapy
18%
B Cell
18%
Immunoglobulin E Antibody
18%
Cytokine
18%
Biological Product
17%
Dendritic Cell
16%
Prevalence
15%
Adalimumab
14%
Immunocompetent Cell
13%
Allele
12%
Psoriatic Arthritis
11%
Autoimmunity
11%
Macrophage
11%
Comorbidity
11%
Monoclonal Antibody
10%
Inflammatory Disorder
10%
Methotrexate
10%
Effector Cell
10%
Homeostasis
10%
Mediator
10%
Regulatory T Cell
9%
Tumor Cell
9%
Immune System
9%
Tumor Antigen
9%
Fibroblast
8%
Immunoglobulin G4
8%
Sensitization
7%
Cancer Cell
7%
Ciclosporin
7%
Ustekinumab
7%
Humoral Immunity
7%
Antibody Drug Conjugate
7%
Food Allergy
7%
Allergen
7%
Ultraviolet Radiation
7%
Loss of Function Mutation
6%
Immunoglobulin G1
6%
Microbiome
6%
Asthma
6%
Autoantibodies
6%
Atopy
6%
Immunopathogenesis
6%
Chondroitin Sulfate Proteoglycan
6%
Immunosurveillance
5%
Normal Human
5%
Basement Membrane
5%
Tumor Necrosis Factor
5%
Single Nucleotide Polymorphism
5%
Extracellular Matrix
5%
Proteomics
5%
Programmed Cell Death
5%
Basophil Activation
5%
Autoimmune Disease
5%
Interleukin 17
5%
Clinical Immunology
5%
Xenograft
5%
Biochemistry, Genetics and Molecular Biology
Epidermolysis bullosa
61%
Genetics
42%
Keratinocyte
35%
Allele
26%
Genomics
20%
Dysplasia
20%
Autosomal Recessive Inheritance
18%
Exon
17%
Fibroblast
16%
Genotyping
12%
Candidate Gene
11%
Autosomal Dominant Inheritance
11%
Missense Mutation
11%
Comorbidity
10%
Gene Expression
10%
Cohort Study
10%
Desmosome
10%
Keratin
10%
Genome-Wide Association Study
10%
Prevalence
10%
Genodermatosis
10%
Integrin
9%
Major Histocompatibility Complex
9%
T Cell
9%
Gene Mutation
9%
Exome Sequencing
9%
Genotype Phenotype Correlation
9%
Next Generation Sequencing
9%
Cytokine
9%
Stem Cell
8%
HLA-C
8%
Autoimmunity
8%
Nonsense Mutation
8%
Genetic Divergence
8%
Plakophilin
8%
Loss of Function Mutation
7%
Genetic Architecture
7%
Genetic Risk
7%
Pedigree
7%
Clinical Trial
7%
Gene Linkage
7%
Induced Pluripotent Stem Cell
6%
Basement Membrane
6%
Synapsin I
6%
Codon
6%
Single-Nucleotide Polymorphism
6%
Extracellular Matrix Protein
6%
Immunoglobulin E
6%
Desmoplakin
6%
Genetic Disorder
6%
Gene Therapy
6%
Intron
5%
Anchoring Fibrils
5%
Homeostasis
5%
Amino Acids
5%
Immune Response
5%
Adalimumab
5%
Programmed Cell Death
5%
Single Nucleotide Polymorphism
5%